e-learning
resources
Munich 2014
Wednesday, 10.09.2014
Current controversies in the management of acute pulmonary embolism
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Anticoagulant treatment of venous thromboembolism: established and new oral agents, remaining questions
F. Klok (Leiden, Netherlands)
Source:
International Congress 2014 – Current controversies in the management of acute pulmonary embolism
Session:
Current controversies in the management of acute pulmonary embolism
Session type:
Symposium
Number:
4614
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Klok (Leiden, Netherlands). Anticoagulant treatment of venous thromboembolism: established and new oral agents, remaining questions. International Congress 2014 – Current controversies in the management of acute pulmonary embolism
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Prospects for the prevention and treatment of venous thromboembolism
Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=155
Year: 2004
Direct oral anticoagulants and low-molecular weight heparin for primary prevention of venous thromboembolism in cancer patients: a meta-analysis
Source: Virtual Congress 2020 – From diagnosis to management of pulmonary embolism
Year: 2020
Potential pharmacological interactions between oral pulmonary arterial hypertension (PAH) therapies and new oral anticoagulants
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
Efficacy and safety of treatment with anticoagulants in patients with unprovoked venous thromboembolism in Korea
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016
Direct oral anticoagulants and venous thromboembolism
Source: Eur Respir Rev 2016; 25: 295-302
Year: 2016
Complications of anticoagulant therapy in patients with pulmonary thromboembolism
Source: Eur Respir J 2007; 30: Suppl. 51, 604s
Year: 2007
Prophylaxis of venous thromboembolism : what is new?
Source: International Congress 2019 – Update on anticoagulant therapy: controversy and progress
Year: 2019
Effectiveness of thrombolytic therapy in pulmonary thromboembolism
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Year: 2007
Prolonged anticoagulation in VTE with direct oral anticoagulants: towards an individual analysis of net clinical benefit?
Source: Eur Respir J 2016; 48: 1268-1270
Year: 2016
Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment
Source: Eur Respir J 2016; 48: 1369-1376
Year: 2016
A single centre experience of low dose direct oral anticoagulants (DOAC) after unprovoked venous thromboembolism (VTE)
Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism
Year: 2019
Managing chronic thromboembolic pulmonary hypertension: pharmacological treatment options
Source: Eur Respir Rev 2009; 18: 24-28
Year: 2009
Efficiency of r-TPA therapy in major venous thromboembolism
Source: Eur Respir J 2007; 30: Suppl. 51, 83s
Year: 2007
Anticoagulant treatment for acute pulmonary embolism: a pathophysiology-based clinical approach
Source: Eur Respir J 2015; 45: 1142-1149
Year: 2015
Rivaroxaban versus standard anticoagulation for the treatment of pulmonary embolism: a real-life study
Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Year: 2019
The evaluation of medication adherence in patients with pulmonary thromboembolism
Source: International Congress 2018 – Acute pulmonary embolism: from diagnosis to treatment
Year: 2018
Thrombolytic therapy in cases with massive pulmonary thromboembolism
Source: Eur Respir J 2005; 26: Suppl. 49, 521s
Year: 2005
Treatment and prevention of cancer-associated venous thromboembolism
Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management
Year: 2021
Comparison of two regimens of oral anticoagulation in pulmonary embolism
Source: Eur Respir J 2006; 28: Suppl. 50, 632s
Year: 2006
Combination therapy for pulmonary arterial hypertension: still more questions than answers
Source: Eur Respir J 2004; 24: 339-340
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept